Report initial virology and biomarker results from the REGN-COV2 treatment trials
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Aug 2020
- Due
- 30 Sep 2020
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Company plans to report initial virology and biomarker results from the REGN-COV2 treatment trials in September 2020.”
What we found
Evidence strength A What the grades mean
Later filings state that initial REGN-COV2 trial data showing reduced viral load was announced in September 2020, within the deadline month. Biomarker results are not separately confirmed.
-
A Regeneron Pharmaceuticals 8-K filed 2020-11-05
“In September 2020, the Company also reported the first data from a descriptive analysis in this trial.” ✓ confirmed on the page
-
A Regeneron Pharmaceuticals 10-Q filed 2020-11-05
“In September 2020, we had announced initial data from the trial showing that REGN-COV2 reduced viral load and time to alleviate symptoms.” ✓ confirmed on the page
Market reaction: the shares moved -6.5% against the S&P 500 over the three sessions around the disclosure (4 Nov 2020 to 9 Nov 2020). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Initial virology and biomarker results from REGN-COV2 treatment trials
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Regeneron Pharmaceuticals? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-REGN-006324 · Corrections policy